IndraLab

Statements

Hydroxychloroquine inhibits SARS-CoV-2 morbidity. 1 / 1

| 1

eidos

"Further , chloroquine and hydroxychloroquine , and off-label antiviral drugs , such as the nucleotide analogue remdesivir , HIV protease inhibitors lopinavir and ritonavir , broad-spectrum antiviral drugs arbidol and favipiravir as well as antiviral phytochemicals available to date may prevent spread of SARS-CoV-2 and morbidity and mortality of COVID-19 pandemic ."

32360480

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine inhibits SARS-CoV-2 morbidity. 1 / 1

INDRA sources:

Databases

Reading